Skip to main content
Erschienen in: Metabolic Brain Disease 1/2015

01.02.2015 | Research Article

Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats

verfasst von: Iclea Rocha Gama, Euclides Marinho Trindade-Filho, Suzana Lima Oliveira, Nassib Bezerra Bueno, Isabelle Tenório Melo, Cyro Rego Cabral-Junior, Elenita M. Barros, Jaqueline A. Galvão, Wanessa S. Pereira, Raphaela C. Ferreira, Bruna R. Domingos, Terezinha da Rocha Ataide

Erschienen in: Metabolic Brain Disease | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Two sources of medium-chain triglycerides—triheptanoin with anaplerotic properties and coconut oil with antioxidant features—have emerged as promising therapeutic options for the management of pharmacoresistant epilepsy. We investigated the effects of ketogenic diets (KDs) containing coconut oil, triheptanoin, or soybean oil on pilocarpine-induced status epilepticus (SE) in rats. Twenty-four adult male Wistar rats were divided into 4 groups and fed a control diet (7 % lipids) or a KD containing soybean oil, coconut oil, or triheptanoin (69.8 % lipids). The ketogenic and control diets had a lipid:carbohydrate + protein ratio of 1:11.8 and 3.5:1, respectively. SE was induced in all rats 20 days after initiation of the dietary treatment, through the administration of pilocarpine (340 mg/kg; i.p.). The latency, frequency, duration, and severity of seizures before and during SE were observed with a camcorder. SE was aborted after 3 h with the application of diazepam (5 mg/kg; i.p.). The rats in the triheptanoin-based KD group needed to undergo a higher number of seizures to develop SE, as compared to the control group (P < 0.05). Total weight gain, intake, energy intake, and feed efficiency coefficient, prior to induction of SE, differed between groups (P < 0.05), where the triheptanoin-based KD group showed less weight gain than all other groups, less energy intake than the Control group and intermediate values of feed efficiency coefficient between Control and other KDs groups. Triheptanoin-based KD may have a neuroprotective effect on the establishment of SE in Wistar rats.
Literatur
Zurück zum Zitat Borges K, Sonnewald U (2012) Triheptanoin—a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? Epilepsy Res 100:239–244PubMedCentralPubMedCrossRef Borges K, Sonnewald U (2012) Triheptanoin—a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? Epilepsy Res 100:239–244PubMedCentralPubMedCrossRef
Zurück zum Zitat Bough KJ, Eagles DA (1999) A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the Rat. Epilepsia 40:138–143PubMedCrossRef Bough KJ, Eagles DA (1999) A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the Rat. Epilepsia 40:138–143PubMedCrossRef
Zurück zum Zitat Cavalheiro EA, Silva DF, Turski WA, Calderazzo-Filho LS, Bortolotto ZA, Turski L (1987) The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Dev Brain Res 37:43–58CrossRef Cavalheiro EA, Silva DF, Turski WA, Calderazzo-Filho LS, Bortolotto ZA, Turski L (1987) The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Dev Brain Res 37:43–58CrossRef
Zurück zum Zitat Fawley JA, Pouliot WA, Dudek FE (2012) Pilocarpine-induced status epilepticus and subsequent spontaneous seizures: lack of effect on the number of gonadotropin-releasing hormone-positive neurons in a mouse model of temporal lobe epilepsy. Neuroscience 203:153–159PubMedCrossRef Fawley JA, Pouliot WA, Dudek FE (2012) Pilocarpine-induced status epilepticus and subsequent spontaneous seizures: lack of effect on the number of gonadotropin-releasing hormone-positive neurons in a mouse model of temporal lobe epilepsy. Neuroscience 203:153–159PubMedCrossRef
Zurück zum Zitat Garg DC, Lasseter KC, Shrotriya RC, Shamblen EC, Shamblen S, Huff JV, Gallagher SC (1996) Pharmacokinetic profile of pilocarpine hydrochloride in subjects with impaired hepatic function. Clin Pharmacol Ther 59:200CrossRef Garg DC, Lasseter KC, Shrotriya RC, Shamblen EC, Shamblen S, Huff JV, Gallagher SC (1996) Pharmacokinetic profile of pilocarpine hydrochloride in subjects with impaired hepatic function. Clin Pharmacol Ther 59:200CrossRef
Zurück zum Zitat Hadera MG, Smeland OB, McDonald TS, Tan KN, Sonnewald U, Borges K (2014) Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy. J Neurochem 129:107–119PubMedCrossRef Hadera MG, Smeland OB, McDonald TS, Tan KN, Sonnewald U, Borges K (2014) Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy. J Neurochem 129:107–119PubMedCrossRef
Zurück zum Zitat Kubova H, Druga R, Lukasiuk K, Suchomelova L, Haugvicova R, Jirmanova I, Pitkanen A (2001) Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 21:3593–3599PubMed Kubova H, Druga R, Lukasiuk K, Suchomelova L, Haugvicova R, Jirmanova I, Pitkanen A (2001) Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 21:3593–3599PubMed
Zurück zum Zitat Lambrechts DAJE, Wielders LHP, Aldenkamp AP, Kessels FGH, Kinderen RJA, Majoie MJM (2012) The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav 23:310–314PubMedCrossRef Lambrechts DAJE, Wielders LHP, Aldenkamp AP, Kessels FGH, Kinderen RJA, Majoie MJM (2012) The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav 23:310–314PubMedCrossRef
Zurück zum Zitat Lucena ALM, Oliveira SL, Ataide TR et al (2010) High-fat diet based on trienantin has no adverse metabolic effects in rats. Eur J Lipid Sci Technol 112:166–172CrossRef Lucena ALM, Oliveira SL, Ataide TR et al (2010) High-fat diet based on trienantin has no adverse metabolic effects in rats. Eur J Lipid Sci Technol 112:166–172CrossRef
Zurück zum Zitat Marina AM, Che Man YB, Nazimah SAH, Amin I (2009) Chemical properties of virgin coconut oil. J Am Oil Chem Soc 86:301–307CrossRef Marina AM, Che Man YB, Nazimah SAH, Amin I (2009) Chemical properties of virgin coconut oil. J Am Oil Chem Soc 86:301–307CrossRef
Zurück zum Zitat Nho HS, Kim YS, Lee HP et al (2003) The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 53:119–128CrossRef Nho HS, Kim YS, Lee HP et al (2003) The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 53:119–128CrossRef
Zurück zum Zitat Nylen K, Likhodii S, Abdelmalik PA, Clarke J, Burnham WM (2005) A comparison of the ability of a 4:1 ketogenic diet and a 6.3:1 ketogenic diet to elevate seizure thresholds in adult and young rats. Epilepsia 46:1198–1204PubMedCrossRef Nylen K, Likhodii S, Abdelmalik PA, Clarke J, Burnham WM (2005) A comparison of the ability of a 4:1 ketogenic diet and a 6.3:1 ketogenic diet to elevate seizure thresholds in adult and young rats. Epilepsia 46:1198–1204PubMedCrossRef
Zurück zum Zitat Nylen K, Velazquez JL, Sayed V, Gibson KM, Burnham WM, Snead OC (2009) The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1(-/-) mice. Biochim Biophys Acta 1790:208–212PubMedCentralPubMedCrossRef Nylen K, Velazquez JL, Sayed V, Gibson KM, Burnham WM, Snead OC (2009) The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1(-/-) mice. Biochim Biophys Acta 1790:208–212PubMedCentralPubMedCrossRef
Zurück zum Zitat Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294PubMedCrossRef Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294PubMedCrossRef
Zurück zum Zitat Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838–841 Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838–841
Zurück zum Zitat Roe CR, Bottiglieri T, Wallace M, Arning E, Martin A (2010) Adult Polyglucosan Body Disease (APBD): anaplerotic diet therapy (triheptanoin) and demonstration of defective methylation pathways. Mol Genet Metab 101:246–252PubMedCrossRef Roe CR, Bottiglieri T, Wallace M, Arning E, Martin A (2010) Adult Polyglucosan Body Disease (APBD): anaplerotic diet therapy (triheptanoin) and demonstration of defective methylation pathways. Mol Genet Metab 101:246–252PubMedCrossRef
Zurück zum Zitat Samala R, Willis S, Borges K (2008) Anticonvulsivant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res 81:119–127PubMedCrossRef Samala R, Willis S, Borges K (2008) Anticonvulsivant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res 81:119–127PubMedCrossRef
Zurück zum Zitat Silveira VG, de Paula CG, Müller AP, Figueiró F, Bonan CD, Perry ML, Battastini AM (2010) Effect of ketogenic diet on nucleotide hydrolysis and hepatic enzymes in blood serum of rats in a lithium-pilocarpine-induced status epilepticus. Metab Brain Dis 25:211–217PubMedCrossRef Silveira VG, de Paula CG, Müller AP, Figueiró F, Bonan CD, Perry ML, Battastini AM (2010) Effect of ketogenic diet on nucleotide hydrolysis and hepatic enzymes in blood serum of rats in a lithium-pilocarpine-induced status epilepticus. Metab Brain Dis 25:211–217PubMedCrossRef
Zurück zum Zitat Thomas NK, Willis S, Sweetman L, Borges K (2012) Triheptanoin in acute mouse seizure models. Epilepsy Res 99:312–317PubMedCrossRef Thomas NK, Willis S, Sweetman L, Borges K (2012) Triheptanoin in acute mouse seizure models. Epilepsy Res 99:312–317PubMedCrossRef
Zurück zum Zitat Willis S, Stoll J, Sweetman L, Borges K (2010) Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol Dis 40:565–572PubMedCentralPubMedCrossRef Willis S, Stoll J, Sweetman L, Borges K (2010) Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol Dis 40:565–572PubMedCentralPubMedCrossRef
Metadaten
Titel
Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats
verfasst von
Iclea Rocha Gama
Euclides Marinho Trindade-Filho
Suzana Lima Oliveira
Nassib Bezerra Bueno
Isabelle Tenório Melo
Cyro Rego Cabral-Junior
Elenita M. Barros
Jaqueline A. Galvão
Wanessa S. Pereira
Raphaela C. Ferreira
Bruna R. Domingos
Terezinha da Rocha Ataide
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 1/2015
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-014-9586-4

Weitere Artikel der Ausgabe 1/2015

Metabolic Brain Disease 1/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.